Dr. Martens (DOCS) Stock Chart & Stock Price History GBX 79.30 +0.15 (+0.19%) As of 11:07 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock Dr. Martens Stock Price Performance The Dr. Martens (DOCS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 9.68%, with a year-to-date return of 9.83%. In the past month, the stock has increased 6.37%, reflecting recent market activity. As of the latest close, Dr. Martens traded at GBX 79.15 with a market cap of £768.36 million and volume of 473,895 shares. Receive DOCS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.02%1 Month Performance+6.37%3 Month Performance+50.19%Year-To-Date Performance+9.83%1 Year Performance+9.68% DOCS Stock Chart for Monday, July, 21, 2025 DOCS Chart by TradingView Dr. Martens Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025GBX 78.80GBX 79.15+0.44%GBX 80.12GBX 78.90473,895 shs£768.36 million07/17/2025GBX 78.50GBX 78.80+0.38%GBX 78.80GBX 77.30826,464 shs£764.96 million07/16/2025GBX 79.35GBX 78.50-1.07%GBX 80GBX 77.65836,571 shs£762.05 million07/15/2025GBX 79.55GBX 79.35-0.25%GBX 80.85GBX 79.201.14 million shs£770.30 million07/14/2025GBX 79GBX 79.55+0.70%GBX 80GBX 76.201.57 million shs£772.24 million07/11/2025GBX 78.70GBX 79+0.38%GBX 79.40GBX 75.30750,626 shs£766.90 million07/10/2025GBX 76.15GBX 78.70+3.35%GBX 78.70GBX 76676,251 shs£763.99 million07/09/2025GBX 76.95GBX 76.15-1.04%GBX 77.25GBX 75.05742,763 shs£739.24 million07/08/2025GBX 77.55GBX 76.95-0.77%GBX 77.70GBX 74.10855,851 shs£747.00 million07/07/2025GBX 76.90GBX 77.55+0.85%GBX 79.25GBX 74677,297 shs£752.83 million Get the Latest News and Ratings for DOCS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025GBX 77.75GBX 77.75GBX 78.50GBX 76.33500,684 shs£754.77 million07/03/2025GBX 76.50GBX 77.75+1.63%GBX 78.50GBX 76.33500,684 shs£754.77 million07/02/2025GBX 76.95GBX 76.50-0.58%GBX 77.90GBX 73.30994,888 shs£742.63 million07/01/2025GBX 75.05GBX 76.95+2.53%GBX 77.10GBX 72.601.18 million shs£747.00 million06/30/2025GBX 77.05GBX 75.05-2.60%GBX 78.15GBX 75.052.61 million shs£728.56 million06/27/2025GBX 74.93GBX 77.05+2.84%GBX 77.05GBX 75.40670,722 shs£747.97 million06/26/2025GBX 74.70GBX 74.93+0.30%GBX 77GBX 74.402.37 million shs£727.34 million06/25/2025GBX 74.60GBX 74.70+0.13%GBX 75.70GBX 741.51 million shs£725.16 million06/24/2025GBX 72.75GBX 74.60+2.54%GBX 74.85GBX 70.251.34 million shs£724.19 million06/23/2025GBX 74.55GBX 72.75-2.41%GBX 74.10GBX 71.626.61 million shs£706.23 million06/20/2025GBX 73.10GBX 74.55+1.98%GBX 74.95GBX 71.551.87 million shs£723.70 million Related Companies Templeton Emerging Markets Investment Trust Stock Price Chart Vistry Group Stock Price Chart Spirent Communications Stock Price Chart Genuit Group Stock Price Chart Wickes Group Stock Price Chart YouGov Stock Price Chart Stelrad Group Stock Price Chart Sylvania Platinum Stock Price Chart Netcall Stock Price Chart Arbuthnot Banking Group Stock Price Chart Receive DOCS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DOCS) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
